Edwards Lifesciences Corporation
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $818.3M | $930.1M | $718.4M | $653.8M | $420.4M | $310.9M | $171.2M | $396.1M |
| Accounts Receivable | $438.7M | $365.5M | $315.4M | $288.0M | $302.5M | $321.1M | $283.8M | $277.3M |
| Inventory | $554.9M | $396.6M | $339.9M | $296.8M | $308.9M | $281.0M | $261.3M | $203.6M |
| Total Current Assets | $2.55B | $2.24B | $2.05B | $2.23B | $1.73B | $1.29B | $1.17B | $1.03B |
| Property, Plant & Equipment | $679.7M | $580.0M | $482.5M | $442.9M | $421.6M | $373.3M | $304.3M | $269.8M |
| Goodwill | $1.13B | $626.1M | $628.3M | $376.0M | $385.4M | $384.7M | $349.8M | $315.2M |
| Intangible Assets (Excl. Goodwill) | $468.0M | $204.8M | $205.4M | $23.4M | $33.5M | $67.0M | $66.9M | $67.1M |
| Total Assets | $5.67B | $4.51B | $4.06B | $3.52B | $2.71B | $2.22B | $1.98B | $1.77B |
| Liabilities | ||||||||
| Accounts Payable | $116.6M | $97.1M | $63.9M | $58.2M | $48.4M | $74.7M | $85.0M | $47.6M |
| Total Current Liabilities | $1.42B | $532.5M | $476.2M | $426.1M | $345.6M | $347.4M | $335.2M | $337.8M |
| Long-Term Debt | $438.4M | $822.3M | $596.9M | $598.1M | $593.1M | $189.3M | — | — |
| Total Liabilities | $2.71B | $1.89B | $1.55B | $1.33B | $1.17B | $754.4M | $653.1M | $459.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $1.96B | $3.91B | $3.34B | $2.84B | $2.03B | $1.65B | $1.36B | $1.12B |
| Total Stockholders' Equity | $2.96B | $2.62B | $2.50B | $2.19B | $1.54B | $1.47B | $1.33B | $1.31B |